Circulating tumor cells as a potential efficacy end point in clinical trials of hormone-resistant prostate cancer

Samir S. Taneja

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)4-5
    Number of pages2
    JournalCurrent Urology Reports
    Volume10
    Issue number1
    DOIs
    StatePublished - Jan 2009

    ASJC Scopus subject areas

    • Urology

    Cite this